ENDRA Life Sciences (NASDAQ:NDRA) Trading 25.3% Higher – What’s Next?

ENDRA Life Sciences Inc. (NASDAQ:NDRA)’s stock price rose 25.3% on Monday . The stock traded as high as $9.85 and last traded at $8.12. Approximately 13,829,535 shares traded hands during trading, an increase of 30,120% from the average daily volume of 45,763 shares. The stock had previously closed at $6.48.

Analyst Ratings Changes

NDRA has been the subject of several research reports. Wall Street Zen cut ENDRA Life Sciences from a “hold” rating to a “sell” rating in a report on Saturday, August 16th. Weiss Ratings reissued a “sell (e+)” rating on shares of ENDRA Life Sciences in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $50.00.

ENDRA Life Sciences Price Performance

The company has a market capitalization of $6.09 million, a price-to-earnings ratio of -0.24 and a beta of -0.09. The business’s 50-day moving average price is $4.89 and its two-hundred day moving average price is $4.62.

ENDRA Life Sciences (NASDAQ:NDRA) last announced its quarterly earnings data on Thursday, August 14th. The company reported ($1.71) earnings per share for the quarter, beating the consensus estimate of ($2.27) by $0.56. As a group, research analysts predict that ENDRA Life Sciences Inc. will post -47.46 EPS for the current year.

About ENDRA Life Sciences

ENDRA Life Sciences Inc develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.